Northern Trust’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-34,589
| Closed | -$604K | – | 4529 |
|
|
2020
Q4 | $604K | Sell |
34,589
-4,432
| -11% | -$62.2K | ﹤0.01% | 3673 |
|
|
2020
Q3 | $457K | Buy |
39,021
+765
| +2% | +$10.2K | ﹤0.01% | 3640 |
|
|
2020
Q2 | $498K | Sell |
38,256
-7,740
| -17% | -$93K | ﹤0.01% | 3550 |
|
|
2020
Q1 | $426K | Buy |
45,996
+589
| +1% | +$8.23K | ﹤0.01% | 3493 |
|
|
2019
Q4 | $754K | Sell |
45,407
-54,876
| -55% | -$890K | ﹤0.01% | 3471 |
|
|
2019
Q3 | $1.67M | Sell |
100,283
-163,696
| -62% | -$2.26M | ﹤0.01% | 3200 |
|
|
2019
Q2 | $3.63M | Sell |
263,979
-34,888
| -12% | -$534K | ﹤0.01% | 2730 |
|
|
2019
Q1 | $5.15M | Buy |
298,867
+8,144
| +3% | +$129K | ﹤0.01% | 2547 |
|
|
2018
Q4 | $3.71M | Buy |
290,723
+2,113
| +0.7% | +$32K | ﹤0.01% | 2684 |
|
|
2018
Q3 | $4.68M | Buy |
288,610
+23,123
| +9% | +$331K | ﹤0.01% | 2718 |
|
|
2018
Q2 | $3.42M | Buy |
265,487
+7,862
| +3% | +$106K | ﹤0.01% | 2911 |
|
|
2018
Q1 | $3.21M | Sell |
257,625
-10,084
| -4% | -$123K | ﹤0.01% | 2843 |
|
|
2017
Q4 | $3.74M | Buy |
267,709
+30,277
| +13% | +$444K | ﹤0.01% | 2783 |
|
|
2017
Q3 | $3.99M | Sell |
237,432
-6,529
| -3% | -$106K | ﹤0.01% | 2772 |
|
|
2017
Q2 | $4.1M | Buy |
243,961
+40,637
| +20% | +$607K | ﹤0.01% | 2740 |
|
|
2017
Q1 | $3.15M | Sell |
203,324
-3,357
| -2% | -$47.9K | ﹤0.01% | 2840 |
|
|
2016
Q4 | $3.09M | Buy |
206,681
+6,033
| +3% | +$84.7K | ﹤0.01% | 2850 |
|
|
2016
Q3 | $2.52M | Buy |
200,648
+23,990
| +14% | +$241K | ﹤0.01% | 2956 |
|
|
2016
Q2 | $1.59M | Sell |
176,658
-10,691
| -6% | -$105K | ﹤0.01% | 3161 |
|
|
2016
Q1 | $1.86M | Buy |
187,349
+1,805
| +1% | +$18.5K | ﹤0.01% | 3032 |
|
|
2015
Q4 | $2.13M | Buy |
185,544
+6,483
| +4% | +$80.2K | ﹤0.01% | 3029 |
|
|
2015
Q3 | $2.42M | Buy |
179,061
+32,241
| +22% | +$437K | ﹤0.01% | 2929 |
|
|
2015
Q2 | $2.03M | Buy |
146,820
+26,795
| +22% | +$362K | ﹤0.01% | 3054 |
|
|
2015
Q1 | $1.69M | Buy |
120,025
+5,598
| +5% | +$76.2K | ﹤0.01% | 3216 |
|
|
2014
Q4 | $1.56M | Sell |
114,427
-1,247
| -1% | -$17K | ﹤0.01% | 3237 |
|
|
2014
Q3 | $1.77M | Buy |
115,674
+53,557
| +86% | +$820K | ﹤0.01% | 3178 |
|
|
2014
Q2 | $1.04M | Sell |
62,117
-3,177
| -5% | -$57.2K | ﹤0.01% | 3381 |
|
|
2014
Q1 | $1.31M | Sell |
65,294
-8,034
| -11% | -$174K | ﹤0.01% | 3316 |
|
|
2013
Q4 | $1.42M | Buy |
+73,328
| New | +$1.3M | ﹤0.01% | 3282 |
|
Northern Trust's OXFD Position: Q1 2021 in Review
Northern Trust sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 34,589 shares — an estimated $604K sold.
Northern Trust first reported a position in OXFD in Q4 2013 and held it in 29 quarters. The position peaked at $5.15M in Q1 2019. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- Northern Trust reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- Northern Trust sold 34,589 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $604K.
- Northern Trust first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 29 quarters.
- Northern Trust's Oxford Immunotec Global PLC Ordinary Shares position peaked at $5.15M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on Northern Trust's 13F filing for Q1 2021, filed 12 May 2021.